Viewing Study NCT07167212


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2025-12-26 @ 11:12 PM
Study NCT ID: NCT07167212
Status: WITHDRAWN
Last Update Posted: 2025-09-18
First Post: 2025-09-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparative Effect of Diaphragmatic Training in Patients With Chronic Non-specific Low Back Pain
Sponsor: Rashid Latif Medical College
Organization:

Study Overview

Official Title: Comparative Effect of Diaphragmatic Training and Myofascial Release on Pain Flexibility and Disability in Patients With Chronic Non-specific Low Back Pain
Status: WITHDRAWN
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: This record is a duplicate of IRCT20220604055072N3, where the trial was prospectively registered. Entered here in error.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background: The diaphragm muscle is a respiratory muscle with postural function. Patients with chronic LBP (CLBP) are more susceptible to diaphragm fatigue than healthy people and, therefore, can likely benefit from exercises designed to improve strength/endurance in this muscle. Studying the results of diaphragmatic training versus myofascial release was a strategy for determining which of them was the most effective in improving pain, flexibility and disability in the patients with chronic non- specific low back pain.

Objective: The objective of the study will be to compare the effect of Diaphragm training and myofascial release back pain patients.

Methods: A randomized clinical trial will be conducted on 44 patients aged 20-45 years. The patients will be randomized using lottery method. Group A will underwent diaphragmatic training with four positions with hot-pack and therapeutic ultrasound as baseline treatment NPRS will be used to measure the intensity of pain, ODI for the measurement of disability and Schober's test for lumbar flexibility before and after the completion of treatment sessions. Group B will receive myofascial release of diaphragm for 15 minutes with two sets of repetition of 10 breaths with a one-minute interval between them. Total duration will be 4 weeks.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: